logo
Select company
Select metric
5.29Cash Ratio
VS
Market
93
Sector
88
Industry
83
History
45
$ 5.07Close
$ 2.3 - $ 10.36 52-Week Range
Ticker Information

Ticker

XBIO

Company Name

XENETIC BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XENETIC BIOSCIENCES INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XBIO - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 4.78M5.29$ 903.43K
3/31/2025$ 5.16M7.73$ 667.93K
12/31/2024$ 6.17M6.89$ 894.26K
9/30/2024$ 6.84M6.78$ 1.01M
6/30/2024$ 7.3M4.6$ 1.59M
3/31/2024$ 7.82M10.92$ 716.49K
12/31/2023$ 8.98M11.1$ 809.59K
9/30/2023$ 9.78M9.15$ 1.07M
6/30/2023$ 10.73M12.31$ 871.32K
3/31/2023$ 11.99M14.01$ 856.37K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XENETIC BIOSCIENCES INC's latest trailing twelve months (TTM) Cash Ratio stands at 8.95.
  • Over the past 5 years, XENETIC BIOSCIENCES INC's average Cash Ratio has been 10.74.
  • The median Cash Ratio for XENETIC BIOSCIENCES INC during this period was 11.38
  • XENETIC BIOSCIENCES INC reached its highest Cash Ratio over the past 5 years at 17.57.
  • The lowest Cash Ratio recorded by XENETIC BIOSCIENCES INC in the same timeframe 4.6

XENETIC BIOSCIENCES INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
ONCO : ONCONETIX INC 0.02SPRB : SPRUCE BIOSCIENCES INC 2.03NAOV : NANOVIBRONIX INC 0.62SXTP : 60 DEGREES PHARMACEUTICALS INC 1.16VIVS : VIVOSIM LABS INC 4.29DRMA : DERMATA THERAPEUTICS INC -SLRX : SALARIUS PHARMACEUTICALS INC 0.36GLTO : GALECTO INC 3.88TOVX : THERIVA BIOLOGICS INC 0.98REVB : REVELATION BIOSCIENCES INC 3.3

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for XENETIC BIOSCIENCES INC is calculated as follows: CashnEq [ $ 7.05M ] / LiabilitesC [ $ 788.47K ]
(=) Cash Ratio [ 8.95 ]

XBIO - Cash Ratio, Last 5 years

4.6

Minimum

Jun 30, 2024

17.57

Maximum

Sep 30, 2021

10.74

Average

11.38

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63